LT3881845T - Trazodono ir gabapentino derinys, skirtas skausmo gydymui - Google Patents

Trazodono ir gabapentino derinys, skirtas skausmo gydymui

Info

Publication number
LT3881845T
LT3881845T LTEP21158825.6T LT21158825T LT3881845T LT 3881845 T LT3881845 T LT 3881845T LT 21158825 T LT21158825 T LT 21158825T LT 3881845 T LT3881845 T LT 3881845T
Authority
LT
Lithuania
Prior art keywords
trazodone
pain treatment
gabapentin combination
gabapentin
combination
Prior art date
Application number
LTEP21158825.6T
Other languages
English (en)
Inventor
Beatrice Garrone
Lucia Durando
Fabrizio CALISTI
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of LT3881845T publication Critical patent/LT3881845T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEP21158825.6T 2015-10-22 2016-10-17 Trazodono ir gabapentino derinys, skirtas skausmo gydymui LT3881845T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15191024 2015-10-22

Publications (1)

Publication Number Publication Date
LT3881845T true LT3881845T (lt) 2025-04-25

Family

ID=54345445

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP21158825.6T LT3881845T (lt) 2015-10-22 2016-10-17 Trazodono ir gabapentino derinys, skirtas skausmo gydymui
LTEP16781816.0T LT3364975T (lt) 2015-10-22 2016-10-17 Trazodono ir gabapentino derinys, skirtas skausmo gydymui

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEP16781816.0T LT3364975T (lt) 2015-10-22 2016-10-17 Trazodono ir gabapentino derinys, skirtas skausmo gydymui

Country Status (28)

Country Link
US (2) US10786498B2 (lt)
EP (2) EP3364975B1 (lt)
JP (1) JP6924184B2 (lt)
KR (1) KR102691296B1 (lt)
CN (1) CN108174599B (lt)
AR (1) AR106415A1 (lt)
AU (1) AU2016341063B2 (lt)
BR (1) BR112018007374B1 (lt)
CA (1) CA2999389C (lt)
CY (1) CY1124229T1 (lt)
DK (2) DK3881845T3 (lt)
EA (2) EA037838B1 (lt)
ES (2) ES3015662T3 (lt)
FI (1) FI3881845T3 (lt)
GE (2) GEAP202014778A (lt)
HR (2) HRP20250248T1 (lt)
HU (2) HUE054653T2 (lt)
IL (1) IL258316B (lt)
LT (2) LT3881845T (lt)
MD (2) MD3881845T2 (lt)
MX (1) MX380433B (lt)
PL (2) PL3881845T3 (lt)
PT (2) PT3881845T (lt)
RS (2) RS66607B1 (lt)
SI (2) SI3881845T1 (lt)
SM (2) SMT202500150T1 (lt)
UA (1) UA122245C2 (lt)
WO (1) WO2017067870A1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900006602A1 (it) * 2019-05-07 2020-11-07 Acraf Composizione farmaceutica per il trattamento del dolore neuropatico
EP3907214A1 (en) * 2020-05-04 2021-11-10 Dompe' Farmaceutici S.P.A. Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE449633T1 (de) 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
WO2005025563A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders
US20080096872A1 (en) * 2004-12-22 2008-04-24 Friedman Robert S Composition for Treatment of Pain Specification
US20120083508A1 (en) * 2006-12-22 2012-04-05 Allergan, Inc. Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain
US9695380B2 (en) * 2007-07-18 2017-07-04 Dow Global Technologies Llc Water-glycol hydraulic fluid compositions
EP2184986A4 (en) 2007-08-06 2010-12-15 Trinity Lab Inc PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY
KR20110028320A (ko) * 2008-07-02 2011-03-17 테바 파마슈티컬 인더스트리즈 리미티드 가바펜틴 에나카르빌 염 및 이의 제조 방법
WO2013002584A2 (ko) 2011-06-28 2013-01-03 주식회사 비보존 다중 타겟팅의 상승 효과를 유발하는 유효물질의 조합 및 그 용도

Also Published As

Publication number Publication date
DK3881845T3 (da) 2025-03-24
HUE054653T2 (hu) 2021-09-28
PT3364975T (pt) 2021-05-27
JP2018531259A (ja) 2018-10-25
EP3881845B1 (en) 2025-01-15
SI3364975T1 (sl) 2021-08-31
UA122245C2 (uk) 2020-10-12
SMT202100352T1 (it) 2021-07-12
CA2999389A1 (en) 2017-04-27
GEAP202014778A (en) 2020-03-10
SI3881845T1 (sl) 2025-05-30
EP3364975A1 (en) 2018-08-29
US20180296553A1 (en) 2018-10-18
HUE071186T2 (hu) 2025-08-28
CA2999389C (en) 2023-12-19
EA202190626A2 (ru) 2021-06-30
AR106415A1 (es) 2018-01-10
AU2016341063A1 (en) 2018-04-26
US10786498B2 (en) 2020-09-29
PT3881845T (pt) 2025-02-13
SMT202500150T1 (it) 2025-05-12
DK3364975T3 (da) 2021-06-21
ES3015662T3 (en) 2025-05-07
HRP20210832T1 (hr) 2021-08-06
PL3881845T3 (pl) 2025-05-12
WO2017067870A1 (en) 2017-04-27
US11752147B2 (en) 2023-09-12
EP3881845A3 (en) 2021-09-29
EA202190626A3 (ru) 2021-09-30
IL258316B (en) 2022-08-01
LT3364975T (lt) 2021-09-10
GEP20207145B (en) 2020-08-25
CY1124229T1 (el) 2022-05-27
MD3881845T2 (ro) 2025-06-30
EA201890911A1 (ru) 2018-09-28
FI3881845T3 (fi) 2025-04-08
HRP20250248T1 (hr) 2025-04-11
BR112018007374A2 (pt) 2018-10-23
MX380433B (es) 2025-03-12
MD3364975T2 (ro) 2021-09-30
RS61989B1 (sr) 2021-07-30
MX2018004532A (es) 2018-09-12
BR112018007374B1 (pt) 2023-11-28
HK1252359A1 (zh) 2019-05-24
JP6924184B2 (ja) 2021-08-25
EP3881845A2 (en) 2021-09-22
RS66607B1 (sr) 2025-04-30
CN108174599A (zh) 2018-06-15
IL258316A (en) 2018-06-28
EP3364975B1 (en) 2021-04-07
PL3364975T3 (pl) 2021-11-02
EA037838B1 (ru) 2021-05-26
KR20180063314A (ko) 2018-06-11
CN108174599B (zh) 2021-09-03
AU2016341063B2 (en) 2022-04-14
KR102691296B1 (ko) 2024-08-05
ES2879392T3 (es) 2021-11-22
US20200316060A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
IL269371A (en) Treatment methods
DK3389778T3 (da) Indretning til fotodynamisk behandling
LT3206497T (lt) Kompozicijos ir būdai, skirti meibomo liaukos disfunkcijos gydymui
EP3756605C0 (en) SKIN TREATMENT DEVICE
DK3142637T3 (da) Keratin treatment formulations and methods
FI20165606A7 (fi) Lämpökäsittely
BR112017018413A2 (pt) tratamento de pancreatite
IL252182B (en) Method for treating cancer
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
DK3231444T3 (da) Ny behandling
EP3215219C0 (en) SKIN TREATMENT SYSTEM
HUE050944T2 (hu) Kezelési eljárás tradipitant alkalmazásával
DK3203834T3 (da) Hovbehandlingsarrangement
DE202014010318U8 (de) Wärmebehandlungsvorrichtung
IL250692A0 (en) Medical treatments based on anamorelin
EP3597225A4 (en) TREATMENT PROCESS
DK3302478T3 (da) Pac-1 kombinations behandling
EP3493821A4 (en) METHOD OF TREATING THE RESPIRATORY TRACT
EP3277726A4 (en) Pain treatment
LT3364975T (lt) Trazodono ir gabapentino derinys, skirtas skausmo gydymui
EP3582781A4 (en) A method of treatment
PL3334479T3 (pl) Urządzenie do przetwarzania krwi
PL3903774T3 (pl) N,n-bis-2-merkaptoetyloizoftalamid do leczenia chorób neurodegeneracyjnych
HRP20181756T1 (hr) Režim liječenja sa spojem tiakumicina
HUE049392T2 (hu) Paroxizmális súlyos fájdalom kezelése